Tag: RSV respiratory syncytial virus

All

FDA OK’s Fast Track Status to mRNA RSV Vaccine

The FDA has granted Fast Track designation to Moderna's investigational single-dose mRNA-1345 vaccine against the respiratory syncytial virus (RSV) for people over 60 years of age.

NICU/PICU Care for Respiratory Syncytial Virus
Clinical Trial of RSV Vaccine Underway
CDC Issues Health Advisory For Respiratory Syncytial Virus
The New Medications That Could Curb Respiratory Syncytial Virus
RSV, Flu to Become More Common But Less Severe Due to Climate Change
Scientists Uncover Structure of HMPV Enzyme
New RSV Vaccine Shows Strong Immune Response

All

Johnson & Johnson to Write-off $900M RSV Fail

Johnson & Johnson is scrapping its investigational therapy for respiratory syncytial virus (RSV) and human metapneumovirus to the tune of a $900 million tax write-off.